The Role of Telemedicine in Child and Adolescent Healthcare in India.

The Role of Telemedicine in Child and Adolescent Healthcare in India.
复制标题

DOI:
10.1007/s40124-021-00253-w
复制
发表时间:
2021
影响因子:
1.9
通讯作者:
Bhargav H
Bhargav H
中科院分区:
其他
文献类型:
--
作者:
Galagali PM;Ghosh S;Bhargav H

文献摘要

参考文献

被引文献

相似文献

我们强调了远程医疗在印度儿童和青少年保健中的发展和使用,在大流行之前和之后的时代。最新研究认可远程医疗是资源有限环境中提供可获得和公平医疗保健的成功战略。印度于2001年启动了远程医疗。大流行限制导致其使用增加。国家远程医疗和远程精神病学准则促进并促成了其广泛使用。城市、农村和偏远地区的私营和公共卫生机构都使用远程保健。它被用于分类病例;管理和监测居家隔离的COVID患者,非COVID医疗和精神病护理以及随访;继续医学教育;以及远程瑜伽等健康促进策略。缺点包括无法提供隐私和保密,无法进行身体检查和提供紧急护理。大多数患者及其护理人员对远程保健服务表示满意。远程医疗很可能成为后疫情时代医疗保健服务不可或缺的一部分。
We highlight the evolution and use of telemedicine in child and adolescent healthcare in India, in pre and post pandemic eras. The latest research endorses telemedicine as a successful strategy in resource-limited settings to provide accessible and equitable healthcare. Telemedicine was initiated in India in 2001. The pandemic restrictions resulted in an increase in its use. The national telemedicine and telepsychiatry guidelines facilitated and enabled its widespread use. Telehealth was used by private and public health establishments, in urban, rural, and remote areas. It was used for triaging cases; managing and monitoring COVID patients in home isolation, in non-COVID medical and psychiatric care, and follow-up; continuing medical education; and health promotion strategies like teleyoga. The shortcomings included inability to provide privacy and confidentiality, perform physical examination, and provide emergency care. Most patients and their caregivers expressed satisfaction with telehealth services. Telemedicine is likely to become an integral part of healthcare services in the post pandemic era.
DOI: 10.1007/s12098-020-03590-8
发表时间: 2021-10
影响因子: 4.3
作者:
Kumari J;Jat KR;Kabra SK
通讯作者: Kabra SK
DOI: 10.1016/j.mjafi.2021.04.001
发表时间: 2021-07
期刊: Medical journal, Armed Forces India
影响因子: --
作者:
Muthukrishnan J;Venugopal N;Basavaraj AP;Bagga G;Jayakrishnan VY;Bharadwaj K;Thoke SV
通讯作者: Thoke SV
DOI: 10.1155/2020/6432476
发表时间: 2020
影响因子: 2.1
作者:
Manglani M;Gabhale Y;Lala MM;Balakrishnan S;Bhuyan K;Rewari BB;Setia MS
通讯作者: Setia MS
DOI: 10.1038/s41386-020-0767-z
发表时间: 2021-01
期刊: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子: --
作者:
Koppe G;Meyer-Lindenberg A;Durstewitz D
通讯作者: Durstewitz D
DOI: 10.1007/s13312-020-1789-7
发表时间: 2020-04-01
期刊: INDIAN PEDIATRICS
影响因子: 2.3
作者:
Dhingra, Dhulika;Dabas, Aashima
通讯作者: Dabas, Aashima